Cybin Inc. is upgraded to Buy, driven by recent regulatory and clinical tailwinds that favor its lead candidate, HLP003.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results